Annual Total Assets
$360.25 M
-$84.06 M-18.92%
December 31, 2023
Summary
- As of February 7, 2025, CNTA annual total assets is $360.25 million, with the most recent change of -$84.06 million (-18.92%) on December 31, 2023.
- During the last 3 years, CNTA annual total assets has risen by +$348.53 million (+2974.56%).
- CNTA annual total assets is now -67.95% below its all-time high of $1.12 billion, reached on June 1, 2020.
Performance
CNTA Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$609.72 M
+$210.87 M+52.87%
September 30, 2024
Summary
- As of February 7, 2025, CNTA quarterly total assets is $609.72 million, with the most recent change of +$210.87 million (+52.87%) on September 30, 2024.
- Over the past year, CNTA quarterly total assets has increased by +$232.35 million (+61.57%).
- CNTA quarterly total assets is now -5.29% below its all-time high of $643.76 million, reached on June 30, 2021.
Performance
CNTA Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
CNTA Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.9% | +61.6% |
| 3 y3 years | +2974.6% | -3.2% |
| 5 y5 years | -58.9% | -3.2% |
CNTA Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.8% | at low | -3.2% | +85.8% |
| 5 y | 5-year | -68.0% | +2974.6% | -5.3% | +90.2% |
| alltime | all time | -68.0% | >+9999.0% | -5.3% | +90.2% |
Centessa Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $609.72 M(+52.9%) |
| Jun 2024 | - | $398.85 M(+21.5%) |
| Mar 2024 | - | $328.17 M(-8.9%) |
| Dec 2023 | $360.25 M(-18.9%) | $360.25 M(-4.5%) |
| Sep 2023 | - | $377.36 M(-4.0%) |
| Jun 2023 | - | $392.92 M(-2.7%) |
| Mar 2023 | - | $403.86 M(-9.1%) |
| Dec 2022 | $444.31 M(-29.4%) | $444.31 M(-7.3%) |
| Sep 2022 | - | $479.36 M(-8.0%) |
| Jun 2022 | - | $521.05 M(-10.5%) |
| Mar 2022 | - | $582.19 M(-7.5%) |
| Dec 2021 | $629.63 M | $629.63 M(+2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $612.21 M(-4.9%) |
| Jun 2021 | - | $643.76 M(+100.8%) |
| Mar 2021 | - | $320.52 M |
| Dec 2020 | $11.72 M(-99.0%) | - |
| Jun 2020 | $1.12 B(+28.4%) | - |
| Jun 2019 | $875.60 M(+8.7%) | - |
| Jun 2018 | $805.77 M(+13.8%) | - |
| Jun 2017 | $708.11 M(+2.7%) | - |
| Jun 2016 | $689.48 M(+44.2%) | - |
| Jun 2015 | $477.99 M(>+9900.0%) | - |
| May 2015 | $7600.00(-88.5%) | - |
| May 2014 | $66.10 K | - |
FAQ
- What is Centessa Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual total assets year-on-year change?
- What is Centessa Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly total assets year-on-year change?
What is Centessa Pharmaceuticals annual total assets?
The current annual total assets of CNTA is $360.25 M
What is the all time high annual total assets for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual total assets is $1.12 B
What is Centessa Pharmaceuticals annual total assets year-on-year change?
Over the past year, CNTA annual total assets has changed by -$84.06 M (-18.92%)
What is Centessa Pharmaceuticals quarterly total assets?
The current quarterly total assets of CNTA is $609.72 M
What is the all time high quarterly total assets for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly total assets is $643.76 M
What is Centessa Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, CNTA quarterly total assets has changed by +$232.35 M (+61.57%)